Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-20

FDA Approved: PRASUGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for prasugrel submitted by Aurobindo Pharma Limited, granting approval of a generic prasugrel product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)